Cardiolyse

Cardiolyse, founded in 2015 and headquartered in Finland, provides a cutting-edge solution in the intersection of healthcare and technology. Specializing in Medical-grade Heart Health AI, the company offers a sophisticated cloud ECG & HRV analytics platform. This technology is designed to enable real-time remote heart health monitoring and delivers personalized, easy-to-understand reports.

The platform stands out by offering up to two months of data-driven prognoses on potentially dangerous heart events. Cardiolyse's innovation focuses on helping individuals aged 45 and older, their families, healthcare providers, and insurance companies gain an in-depth insight into cardiovascular health and long-term trends. It also provides predictive analytics, offering a six-month forecast for serious cardiovascular events, highlighting an opportunity for proactive healthcare management.

In August 2022, the company received a $100.00K investment through a Support Program courtesy of Google. This investment underscores Cardiolyse's potential in the realms of analytics and digital health, with its advanced use of machine learning and medical devices set to offer significant value in the health and wellness sector.